EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Developing Up-Scale Allogeneic Chondrocyte Therapies Using Juvenile Donor Cartilage

Charlotte H Hulme, Jade Perry iD, Helen S McCarthy iD, Tian Lan, Thavisha Ranasinghe, Nigel Kiely, Robert Freeman, Jonathan Wright iD, Karina T Wright

International Journal of Molecular Sciences · 30.09.2025 · 26 (19) · 9566

DOI: 10.3390/ijms26199566 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 30.09.2025. Verfasst von Charlotte H Hulme und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Regenerative Medicine Research, School of Life Sciences, Keele University, Keele, Stoke-on-Trent ST5 5BG, Staffordshire, UK. Hauptthemen laut MEDLINE: Chondrocytes, Cartilage. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, National Institute for Health and Care Research (NIHR).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Allogeneic chondrocyte therapies present an attractive alternative to existing autologous therapies for the repair of cartilage defects, enabling the selection of optimal donor cells and streamlined manufacturing processes. This study investigates the potential of juvenile chondrocytes derived from human infantile (aged 0–4 y) polydactyly digits and the iliac apophysis for cartilage repair using Good Manufacturing Practice bioreactor expansion. Iliac apophysis (n = 4) and polydactyly tissues (n = 4) were assessed histologically. Chondrocytes were isolated enzymatically and cultured using standard tissue culture plastic (TCP) methodology. Upon sufficient cell expansion, chondrocytes were seeded into the Quantum® bioreactor system or onto TCP (±vitronectin coating). The manufactured chondrocytes growth rates, total cell yields, chondrogenic pellet forming capacity (GAG/DNA, histology), immunoprofiles (flow cytometry) and gene expression (RT-qPCR) were assessed. Equivalent chondrocyte numbers were isolated from polydactyly and iliac apophysis donors per wet weight of tissue. Quantum®-expanded chondrocytes from both sources yielded comparable cell numbers; however, growth was slowed in the Quantum® compared to TCP. Polydactyly and iliac apophysis-derived chondrocytes expressed chondrocyte cell surface markers (CD166, CD44, CD151, SOX9) and formed chondrogenic pellets. Quantum® bioreactor expansion did not alter, gene expression or capacity to form glycosaminoglycans (GAGs (normalised to DNA content)) compared to matched TCP expansion. Juvenile cartilage donors are a promising chondrocyte source for the development of an allogeneic therapy. This novel study expanding juvenile chondrocytes in the Quantum® GMP-compliant bioreactor suggests that culture conditions may need modification to improve growth, whilst retaining cartilage forming capacity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChondrocytesCartilageHumansChondrogenesisCells, CulturedInfantChild, PreschoolBioreactorsTissue DonorsInfant, NewbornGlycosaminoglycansTransplantation, HomologousCell Culture TechniquesMale

Stichwörter der Autor:innen

allogeneic cell therapycartilage cell repairchondrocyteshollow-fibre bioreactoriliac apophysis chondrocyteslarge-scale expansionpolydactyly chondrocytes

Substanzen

Glycosaminoglycans

Autor:innen und Institutionen

  • Centre for Regenerative Medicine Research, School of Life Sciences, Keele University, Keele, Stoke-on-Trent ST5 5BG, Staffordshire, UK.
  • Oswestry Keele Orthopaedic Research Group, Robert Jones and Agnes Hunt Orthopaedic Hospital Foundation Trust, Oswestry SY10 7AG, Shropshire, UK.
  • Limb Reconstruction Unit, Royal National Orthopaedic Hospital, Stanmore, London HA7 4LP, UK.
  • National Institute for Health and Care Research (NIHR) Birmingham Biomedical Research Centre, Birmingham B15 2GW, West Midlands, UK.

ORCID-Profile: Jade Perry, Helen S McCarthy, Jonathan Wright

Förderung

  • Medical Research Council
  • National Institute for Health and Care Research (NIHR)

Zitieren

APA

Hulme, C. H., Perry, J., McCarthy, H. S., Lan, T., Ranasinghe, T., Kiely, N., Freeman, R., Wright, J., & Wright, K. T. (2025). Developing Up-Scale Allogeneic Chondrocyte Therapies Using Juvenile Donor Cartilage. International Journal of Molecular Sciences, 26(19), 9566. https://doi.org/10.3390/ijms26199566

Vancouver

Hulme CH, Perry J, McCarthy HS, Lan T, Ranasinghe T, Kiely N, et al. Developing Up-Scale Allogeneic Chondrocyte Therapies Using Juvenile Donor Cartilage. International Journal of Molecular Sciences. 2025;26(19):9566. doi:10.3390/ijms26199566

BibTeX
@article{Hulme2025,
  author = {Hulme, Charlotte H and Perry, Jade and McCarthy, Helen S and Lan, Tian and Ranasinghe, Thavisha and Kiely, Nigel and Freeman, Robert and Wright, Jonathan and Wright, Karina T},
  title = {Developing Up-Scale Allogeneic Chondrocyte Therapies Using Juvenile Donor Cartilage},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {19},
  pages = {9566},
  doi = {10.3390/ijms26199566}
}
Kostenlos starten →